BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report released on Friday morning. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Trading Down 27.9 %

Shares of BIOLASE stock opened at $0.01 on Friday. The business’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01. BIOLASE has a twelve month low of $0.02 and a twelve month high of $1.94. The stock has a market capitalization of $300,663.00, a P/E ratio of 0.00 and a beta of 0.67.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.